HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timothy B Doyle Selected Research

CBR 2092

7/2008In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Timothy B Doyle Research Topics

Disease

2Infections
10/2021 - 07/2008
1Cystic Fibrosis (Mucoviscidosis)
09/2021
1Bacterial Infections (Bacterial Infection)
07/2008

Drug/Important Bio-Agent (IBA)

2RifamycinsIBA
07/2008 - 07/2008
1AztreonamFDA LinkGeneric
10/2021
1avibactamIBA
10/2021
1tazobactam drug combination ceftolozaneIBA
09/2021
1ceftazidime drug combination avibactamIBA
09/2021
1QuinolonesIBA
07/2008
1Anti-Bacterial Agents (Antibiotics)IBA
07/2008
1CBR 2092IBA
07/2008